# Registry to Evaluate INOmax in Newborn Babies With Pulmonary Hypertension

> **NCT03132428** · — · TERMINATED · sponsor: **Mallinckrodt** · enrollment: 140 (actual)

## Conditions studied

- Pulmonary Hypertension of Newborn

## Interventions

- **DRUG:** INOmax

## Key facts

- **NCT ID:** NCT03132428
- **Lead sponsor:** Mallinckrodt
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2017-07-27
- **Primary completion:** 2020-02-11
- **Final completion:** 2020-02-11
- **Target enrollment:** 140 (ACTUAL)
- **Why stopped:** Positive results at interim analysis
- **Last updated:** 2020-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03132428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03132428, "Registry to Evaluate INOmax in Newborn Babies With Pulmonary Hypertension". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03132428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*